Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...

Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on ...

GLP-1 receptor agonist weight loss drugs can negatively interact with eating disorder psychopathology and treatment in ...

The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved ...

Kwame Raoul’s office sent cease and desist letters to five unnamed medical spas in the Chicago area that were allegedly ...

Experimental weight-loss drug Retatrutide shows promise, helping obese adults lose up to 22% of their weight in 48 weeks.

The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a ...

has just become the first drug approved by the U.S. Food and Drug Administration to treat obstructive sleep apnea. Studies ...

The first medication for obstructive sleep apnea has been approved by the US Food and ... “Zepbound promotes weight loss and has been shown to reduce apnea events,” Troxel noted.

For about 25 million Americans who suffer from obstructive sleep apnea, there are various effective treatments such as CPAP breathing machines, surgery, a dental mouthpiece and even an implantable pac ...

Other common weight-loss medications like Ozempic ... expanded Medicaid coverage to include medications with semaglutide specifically approved for obesity, such as Wegovy and Zepbound.